In the majority opinion, Justice Stephen Breyer wrote that the current “regulatory language” is “ambiguous,” and future cases concerning physicians prescribing controlled substances must prove the treatment lacked a “legitimate medical purpose” and the physician knew so. Experts told CNN the ruling will make it more difficult to prosecute physicians in similar cases.
The two defendants were Xiulu Ruan, MD, and Shakeel Kahn, MD, who ran pain management practices in Alabama and Arizona, respectively, according to CNN.
Editor’s note: This article was updated June 28 at 9:35 a.m. CT.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
